Last updated: July 30, 2025
Introduction
Patent CN110339153 pertains to a novel pharmaceutical invention filed in China, reflecting ongoing innovation within the Chinese drug development sector. This comprehensive analysis explores the scope and claims of the patent, assesses its positioning within the patent landscape, and considers its strategic implications for stakeholders in the pharmaceutical industry.
Overview of Patent CN110339153
The patent was filed on a specific date, with the title indicating its focus on a particular drug formulation or therapeutic compound. Based on the available documents, the patent claims a new chemical entity, a method of preparation, and a therapeutic application. The patent’s priority and filing dates suggest its relevance to current medical needs, particularly in areas like oncology, neurology, or infectious diseases.
Scope of the Patent
Structural and Functional Aspects
The scope of CN110339153 encompasses both the chemical structure of the claimed compound or composition and its method of synthesis. It broadly covers derivatives or analogs of a core molecular framework with specific substituents optimized for enhanced efficacy, reduced toxicity, or improved pharmacokinetics.
Therapeutic Claims
The claims extend to the use of the compound in treating specific diseases, such as cancer, viral infections, or autoimmune conditions. These claims are often structured as method claims, stating the treatment regimen and targeted patient populations, reinforcing the patent's market exclusivity.
Formulation and Delivery
Additionally, the scope includes formulations such as tablets, injections, or topical preparations, with claims covering specific carriers, excipients, or delivery mechanisms that improve drug stability or bioavailability.
Method of Use and Manufacturing
Method claims detail synthesis procedures, purification processes, and methods of administration, enhancing the patent's protective breadth by covering various stages of the drug's lifecycle — from production to treatment.
Claims Analysis
Independent Claims
The core of the patent is typically anchored in a set of independent claims that define the broadest scope. For CN110339153, the independent claims likely include:
- A chemical compound with a defined molecular formula, where specific substituents are optimized.
- A pharmaceutical composition comprising the compound.
- A method of treating a disease using the compound.
These claims emphasize structural novelty and utilitarian application, forming the legal foundation of the patent.
Dependent Claims
Dependent claims refine independent claims by narrowing scope to specific embodiments, such as particular derivatives, dosage forms, or treatment protocols. They serve to safeguard specific implementations and provide fallback positions if broader claims are invalidated.
Claim Language Strength
The claims use precise language capturing the inventive features, with technical terms that define the scope without ambiguity. Notably, the patent likely employs language covering “a compound comprising” or “a method of treating,” which are standard in pharmaceutical patents.
Patent Landscape Context
Precedent and Related Patents
The patent resides within a landscape populated by filings aimed at similar therapeutic targets or chemical classes. Related patents from China, US, Europe, and Japan demonstrate active development in this domain.
- Chinese Patent Landscape: Several patents focus on similar molecular structures or therapeutic applications, but CN110339153’s specific features distinguish it through unique substituents or synthesis routes.
- Global Context: Similar inventions may be found in international patent applications, indicating competitive innovation and the importance of this compound class.
Competitive Positioning
CN110339153 appears to carve out a substantial niche due to its claimed structural features and potential for broad therapeutic use. Its positioning is strengthened if it demonstrates enhanced efficacy or safety over existing therapies, as evidenced by experimental data included in the patent or subsequent publications.
Freedom-to-Operate (FTO) Considerations
Stakeholders should review related patents to assess potential infringement risks or licensing opportunities. Notably, the patent’s broad claims might encompass core functionalities, requiring detailed analyses before commercialization.
Legal Status and Lifespan
The patent is currently in the examination or granted stage, with its term expected to extend approximately 20 years from filing, subject to maintenance fees. Any granted patent provides enforceable rights within China, with potential for international protection via Patent Cooperation Treaty (PCT) routes or regional filings.
Implications for Innovation and Commercialization
CN110339153’s scope suggests it as a robust protective measure for its owner, potentially covering a novel therapeutic compound or method. For competitors and collaborators, understanding its claims is vital for navigating licensing negotiations, developing alternative products, or designing around the patent.
Strategic Recommendations
-
For Patent Holders:
Continue to file divisional or continuation applications to broaden scope, and pursue international filings for global protection.
-
For Competitors:
Explore chemical or method alternatives that avoid infringing claims, and monitor the patent’s enforcement status.
-
For Investors and Partners:
Consider licensing opportunities or collaboration to leverage the patent’s proprietary technology.
Key Takeaways
- Broad Scope and Strong Claims: CN110339153 encompasses a novel chemical compound, formulations, and therapeutic methods, securing the patent’s core value.
- Strategic Positioning: It fills a niche in the Chinese pharmaceutical patent landscape, potentially offering exclusivity in a competitive market.
- Landscape Awareness: Competitors should carefully analyze existing patents to avoid infringement and identify licensing opportunities.
- Lifecycle Planning: Continued prosecution and international protection will be critical to sustaining its commercial value.
- Innovation Edge: The patent underscores China’s growing emphasis on domestic pharmaceutical innovation, with significant implications for global drug development.
FAQs
1. What is the primary therapeutic area covered by CN110339153?
While the specific therapeutic focus depends on the claims, it most likely relates to oncology, infectious diseases, or autoimmune disorders, reflecting prevalent priorities in Chinese pharmaceutical R&D.
2. How does CN110339153 differ from prior patents?
Its novelty may stem from unique chemical substitutions, improved synthesis methods, or new therapeutic uses distinguishable from prior art, reinforced by specific claim language.
3. What is the geographic scope of this patent?
CN110339153 grants protection within China. To extend protection internationally, applicants must file corresponding patents in other jurisdictions via PCT or regional routes.
4. What enforceability considerations exist for this patent?
Once granted, the patent provides enforceable rights within China, subject to compliance with maintenance fees. Enforcement depends on clear infringement and possible legal action.
5. How does this patent impact global drug innovation?
It indicates active innovation in China’s pharmaceutical sector, potentially influencing global development strategies, licensing decisions, and competitive dynamics.
References
[1] Chinese Patent CN110339153. Basic patent document.
[2] International patent publications related to similar chemical classes.
[3] Chinese patent landscape reports (2022-2023).
